Graphite Bio, Inc. (NASDAQ:GRPH) Q4 2025 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the LENZ Therapeutics Year-end 2025 Financial Results Conference Call. [Operator Instructions] As a reminder, this call is being recorded.





